Results 111 to 120 of about 3,057,903 (256)

Institutions, Firms and Economic Growth [PDF]

open access: yes
This paper reviews the literature on institutions and explores the ways in which institutions can influence economic growth, with a particular focus on how institutions affect the use that firms make of human capital to improve their productivity.
Jane Frances
core  

Fibrodysplasia ossificans progressiva: from clinical complexity to therapeutic opportunity

open access: yesJournal of Rare Diseases
Fibrodysplasia Ossificans Progressiva (FOP) is an ultra-rare and severely disabling genetic disorder affecting approximately one in two million individuals worldwide. It is characterised by progressive endochondral heterotopic ossification (HO), in which
Amrita Chakraborty   +6 more
doaj   +1 more source

Dyslipidemia and peripheral arterial disease

open access: yesIndian Heart Journal
Peripheral arterial disease (PAD) affects 12 % of adult population and is increasing globally and in India. Peripheral arterial disease when associated with atherosclerosis in two or more other arterial beds such as coronary artery disease (CAD ...
Ajay Yadav   +3 more
doaj   +1 more source

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Annual report 2016: CGIAR Research Program on Policies, Institutions, and Markets

open access: yes, 2017
CGIAR Research Program on Policies, Institutions, and Markets 2016 Annual ...
CGIAR Research Program on Policies, Institutions, and Markets
core  

A comprehensive review on resorcinol and its derivatives: synthetic strategies and pharmacological significance

open access: yesDiscover Chemistry
Resorcinol (1, 3-dihydroxy benzene) is a basic chemical intermediate, which is widely used in the production of polymers, pharmaceuticals, agrochemicals, and specialty materials.
Sanjit Kalita   +6 more
doaj   +1 more source

ABL kinase‐dependent phosphorylation of SH proteins promotes their direct interaction with CRK family SH2 domains

open access: yesFEBS Letters, EarlyView.
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens   +8 more
wiley   +1 more source

Annual progress report 2013: CGIAR Research Program on Policies, Institutions and Markets

open access: yes, 2014
Annual progress report 2013: CGIAR Research Program on Policies, Institutions and Markets ...
CGIAR Research Program on Policies, Institutions, and Markets
core  

Reconstructing enzyme evolution by protein engineering

open access: yesFEBS Letters, EarlyView.
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler   +2 more
wiley   +1 more source

Decoding the dynamic extracellular matrix in cancer—3D models and bioscaffolds rewire the rules of tumor progression

open access: yesFEBS Letters, EarlyView.
Cancer progression is regulated by the dynamic matrix code of the tumor microenvironment, which influences cellular behavior and disease development. Importantly, matrix remodeling in three‐dimensional cancer models more accurately reflects in vivo conditions compared to conventional two‐dimensional systems.
Sylvia Mangani   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy